DynPort Vaccine Company LLC A CSRA Company Revenue and Competitors
Estimated Revenue & Valuation
- DynPort Vaccine Company LLC A CSRA Company's estimated annual revenue is currently $40.3M per year.
- DynPort Vaccine Company LLC A CSRA Company's estimated revenue per employee is $155,000
Employee Data
- DynPort Vaccine Company LLC A CSRA Company has 260 Employees.
- DynPort Vaccine Company LLC A CSRA Company grew their employee count by -33% last year.
DynPort Vaccine Company LLC A CSRA Company's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Associate Director Regulatory Operations | Reveal Email/Phone |
2 | Director, Maufactuing Testing and Technical Services | Reveal Email/Phone |
3 | Sr. Contracts Manager | Reveal Email/Phone |
4 | Senior Quality Assurance Manager | Reveal Email/Phone |
5 | Executive Assistant to the President | Reveal Email/Phone |
DynPort Vaccine Company LLC A CSRA Company Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 30485 | 4% | N/A | N/A |
What Is DynPort Vaccine Company LLC A CSRA Company?
DynPort Vaccine Company LLC manages product development programs for U.S. and international government agencies, and provides consulting, technical and program management services to companies in the biotechnology and pharmaceutical industries. At DynPort, we're helping the government protect soldiers and civilians against emerging diseases and possible bioterror threats. We're doing important work, protecting our nation’s health and security. Learn more about how we can work together at: www.gdit.com/dvc. View our open positions at https://gdit.com/job-results?key=dvc&loc=&combine_2=All
keywords:N/A
N/A
Total Funding
260
Number of Employees
$40.3M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Frederick
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $75.1M | 272 | 8% | N/A |
#2 | $45.1M | 283 | 55% | N/A |
#3 | $75M | 312 | 5% | N/A |
#4 | $15M | 376 | 15% | N/A |
#5 | $77.4M | 427 | -18% | N/A |